Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merrem I.V. Shortage May Continue Into 2006

This article was originally published in The Pink Sheet Daily

Executive Summary

Short supply of AstraZeneca's antibiotic is attributed to manufacturing delays and increased demand.

You may also be interested in...



Merrem I.V. Shortage Due To Increased Regional Demand, AstraZeneca Says

FDA’s website states the antibiotic shortage stems from “manufacturing delays due to bulk drug supply shortages.” The company does not plan to ration shipments to U.S. regions that are not experiencing increased demand.

Mail-Order Pharmacy Not Necessarily Cheaper To Health Plans, Ohio Finds

Health plans should account for the rise in utilization that occurs with use of mail-order pharmacy when deciding if mail order saves money, Ohio Public Employees Retirement System Director of Healthcare Scott Streator said at the recent Academy of Managed Care Pharmacy Educational Conference in Chicago

Lipitor Pricing Offsets Loss In Prescription Volume, Pfizer Says

Declines in Lipitor's prescription volume due to the presence of generic simvastatin are being offset by price increases, Pfizer says

Topics

UsernamePublicRestriction

Register

PS061488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel